Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and approve the standalone and consolidated ....
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed exchanges that its Board of Directors will meet on Tuesday, August 5, 2025. The agenda includes considering and approving the standalone and consolidated unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The company has also reminded that the trading window for designated persons has been closed since July 1, 2025, and will reopen 48 hours after the results are declared, as per SEBI insider trading rules.
This is a routine intimation with no material information for shareholders. Investors should watch for the actual Q1 FY26 results on August 5, which will provide visibility on revenue growth, margins, and profitability for the first quarter.